Table 4. Final clinical diagnoses in the FNB and TCB groups by site biopsied.
Diagnosis by site biopsied | FNB (n = 41) | TCB (n = 37) |
Abdominal node/mass | Left adrenal (2) | Left adrenal (4) |
Metastatic HCC (1) | Metastatic NSCLC (1) | |
Metastatic NSCLC (1) | Metastatic SCCA (1) | |
Benign adrenal (2) | ||
Portahepatis lymph node (5) | Portahepatis lymph node (3) | |
Metastatic GIST (1) | NHL (2) | |
NHL (1) | Metastatic duodenal cancer (1) | |
Granulomatous disease (2) | ||
Metastatic SCLS (1) | ||
Retroperitoneal mass (3) | Celiac lymph node (1) | |
Metastatic thymoma (1) | Metastatic ovarian cancer (1) | |
NHL (1) | ||
Postoperative fat necrosis (1) | ||
Pancreatic head/uncinate | PDAC (3) | PDAC (2) |
CP (1) | ||
PET (1) | ||
NHL (1) | ||
Pancreatic neck/body/tail | PDAC (2) | PDAC (2) |
CP (3) | CP (1) | |
AIP (1) | AIP (1) | |
Normal pancreas | RCC (1) | |
Left lobe liver | NASH without fibrosis (3) | Nonspecific hepatitis (3) |
Steatosis (1) | NASH without fibrosis (2) | |
Normal liver (1) | NASH with early fibrosis (1) | |
Metastatic breast cancer (1) | NASH with cirrhosis (1) | |
Unknown (1) | Biliary cirrhosis (1) | |
Gastric wall/mass | Leiomyoma (5) | GIST (2) |
GIST (2) | Leiomyoma (1) | |
NHL (1) | ||
Pancreatic rest (1) | ||
Posterior mediastinal lymph node or mass | Mediastinal mass (4) | Subcarinal node (5) |
NHL (1) | Reactive node (3) | |
NSCLC (1) | NHL (2) | |
Suggestive of NHL (1) | Metastatic NSCLC (1) | |
AML (1) | ||
Paraesophageal node (2) | ||
Metastatic melanoma (1) | ||
Unknown (1) | ||
Esophageal wall | Leiomyoma (1) | Leiomyoma (1) |
Abbreviations: FNB, fined needle biopsy; TCB, Tru-Cut biopsy; HCC, hepatocellular carcinoma; NSCLC, non-small cell lung cancer; GIST, gastrointestinal stromal tumor; SCLC, small cell lung cancer; NHL, non-Hodgkin’s lymphoma; SCCA, squamous cell carcinoma; PDAC, pancreatic ductal adenocarcinoma; CP, chronic pancreatitis; PET, pancreatic endocrine tumor; AIP, autoimmune pancreatitis; RCC, renal cell carcinoma; NASH, nonalcoholic steatohepatitis.